Hearing Loss Is an Alzheimer's Risk Factor. The 2024 Lancet Commission Made It Official.

Here is the single most underappreciated fact in dementia prevention:

Untreated hearing loss is the largest modifiable risk factor for dementia in midlife. Larger than smoking. Larger than physical inactivity. Larger than social isolation. Larger than high blood pressure.

That is not a wellness-industry claim. It is the conclusion of the Lancet standing Commission on dementia prevention — the most rigorous systematic review of the evidence that exists — updated most recently in August 2024 (Livingston et al., PMID 39096926). Across 14 modifiable risk factors spanning the lifespan, hearing loss has the highest population attributable fraction of any midlife exposure: approximately 7% of all dementia cases worldwide are attributable to untreated hearing loss.

To put that in context: if we could wave a wand and correct hearing loss across the population, we would prevent more dementia than if we eliminated smoking, obesity, hypertension, and excessive alcohol combined in midlife.

And yet the average person waits 7 to 10 years after first noticing hearing loss before they get a hearing aid. The consequences of that delay are now quantifiable — and they show up in the brain.

This article walks through the evidence: what the Lancet Commission actually found, the three mechanistic hypotheses linking hearing to cognition, the first randomized controlled trial showing hearing aids can slow cognitive decline (ACHIEVE, 2023), why most people wait a decade to treat it, and what to do about your own ears starting today.

TL;DR -- Key Takeaways

• The 2024 Lancet Commission (PMID 39096926) ranks untreated hearing loss as the #1 modifiable midlife risk factor for dementia — population attributable fraction approximately 7%
• The 2020 Lancet report placed it even higher at 8% (PMID 32738937); both reports identify hearing loss as the single largest midlife factor
• The ACHIEVE trial (Lin et al. 2023, PMID 37478886) — first RCT of hearing aids for cognitive decline — showed a 48% relative reduction in 3-year cognitive decline in high-risk older adults (the primary analysis in the full population was null; the high-risk ARIC subgroup was significant)
• UK Biobank data (N=437,704) found 42% higher dementia risk in untreated hearing loss; hearing aid users had risk similar to people with normal hearing (PMID 37054721)
• Three mechanisms converge: cognitive load ("effortful listening" steals resources from memory), accelerated brain atrophy in temporal regions, and social isolation
• Median delay from onset of hearing loss to first hearing aid: 7-10 years — mostly driven by stigma, cost, and lack of awareness
• Strongest evidence-based actions: get a baseline audiogram at age 50 (every 3 years after), treat any hearing loss aggressively with hearing aids, protect from loud sound using the 85 dB / distance / duration rules, and quit smoking (also an independent dementia risk factor)

The Lancet Commission: What It Is and Why It Matters

The Lancet Commission on dementia prevention, intervention, and care is a standing panel of 27+ international dementia researchers — neurologists, epidemiologists, psychiatrists, geriatricians — that periodically reviews the entire global evidence base on what causes dementia and what prevents it. Their reports, published in The Lancet (the flagship medical journal, not a specialty spin-off), represent the highest level of evidence synthesis available.

The original 2017 commission identified 9 modifiable risk factors. The 2020 update (PMID 32738937) expanded to 12. The 2024 update (PMID 39096926) expanded again to 14, adding high LDL cholesterol and untreated vision loss. Their headline finding in 2024: approximately 45% of dementia cases are potentially preventable if all 14 risk factors were eliminated.

And every single version of the commission — 2017, 2020, 2024 — has ranked hearing loss as the largest single modifiable risk factor in midlife.

The Exact Numbers from 2024

The commission calculates something called a population attributable fraction (PAF) — the proportion of dementia cases in the population that could theoretically be prevented if a given risk factor were eliminated. For untreated hearing loss in midlife, the 2024 PAF is ~7% (down slightly from 8% in 2020 after revised prevalence estimates, still #1 midlife).

For comparison, here are other midlife PAFs from the 2024 commission:

• Hearing loss (untreated): ~7% ← largest
• High LDL cholesterol (new in 2024): ~7%
• Traumatic brain injury: ~3%
• Hypertension: ~2%
• Obesity: ~1%
• Excessive alcohol: ~1%

And from later life:

• Smoking: ~5%
• Depression: ~3%
• Social isolation: ~4%
• Physical inactivity: ~2%
• Diabetes: ~1%
• Air pollution: ~2%
• Vision loss (new in 2024): ~2%

The message is blunt: of everything you can change about how you live between ages 40 and 65, the thing most likely to protect your brain is treating your ears. Most people don't know this. Most physicians don't emphasize it. The Lancet Commission is trying, year after year, to change that.

Why Ears and Brains Are Connected: Three Mechanisms

Hearing loss and dementia are not just statistically associated. There are three plausible, partially overlapping biological mechanisms — and the 2024 Lancet Commission explicitly lists all three as contributing.

1. Cognitive Load (Effortful Listening)

When auditory input is degraded, the brain has to work harder to make sense of it. Functional MRI studies show that people with hearing loss recruit more prefrontal cortex (the executive-function region) to process speech. That recruitment is not free. Every neuron committed to decoding a fuzzy sentence is a neuron not available for encoding the memory of what was said.

Over decades, this constant compensation may exhaust cognitive reserve — the brain's resilience to damage, built over a lifetime through education, mental stimulation, and healthy networks. People with more reserve can tolerate more Alzheimer's pathology before symptoms emerge. Hearing loss may be eroding that buffer.

2. Accelerated Brain Atrophy

Structural MRI studies show that people with hearing loss lose brain volume faster than people with normal hearing — particularly in the temporal lobe and auditory cortex. A 2014 paper from the Baltimore Longitudinal Study of Aging (Lin et al., PMID 24412398) quantified roughly an additional ~1 cm³ of whole-brain volume loss per year in people with hearing impairment, concentrated in regions critical for memory and language.

The leading interpretation: sensory deprivation causes the auditory system to physically shrink, the way a limb atrophies in a cast. And because auditory cortex borders memory regions like the hippocampus, the damage may spread.

3. Social Isolation

This is the most intuitive mechanism. When hearing gets worse, conversations get exhausting. People stop going to dinner parties. They stop calling friends. They stop going to church or community centers. They pretend to follow along at family gatherings and withdraw.

Social isolation is itself on the Lancet's list of modifiable dementia risk factors — and hearing loss is a major upstream driver of it. A 2017 analysis of the Health ABC study by Deal et al. (PMID 27071780) showed that part of the hearing-dementia link is statistically mediated by reduced social engagement. You can't build cognitive reserve through meaningful human connection if you can't hear the connection.

Most researchers believe these three mechanisms act together. Degraded input forces compensatory load, accelerates structural atrophy, and drives withdrawal. The combined effect is a brain that ages faster.

The ACHIEVE Trial: The First RCT of Hearing Aids for Cognition

Observational data is suggestive but can always be confounded. To prove that hearing aids cause slower cognitive decline, you need a randomized controlled trial. For decades, there wasn't one. In September 2023, there finally was.

The ACHIEVE trial (Lin FR et al., The Lancet, PMID 37478886) randomized 977 adults aged 70-84 with untreated mild-to-moderate hearing loss to receive either (a) professionally fitted hearing aids plus audiologic counseling, or (b) a health education control (diet, exercise, falls prevention). Participants were followed for 3 years with standardized cognitive testing.

The headline result in the full population was null. Across all 977 participants, the hearing aid group did not show statistically significant slower cognitive decline than the control group. If you stopped reading at the abstract, you would conclude hearing aids don't help cognition.

But the design was smarter than that. ACHIEVE was pre-specified to analyze two subgroups:

1. Healthy de novo volunteers (recruited from the community) — generally healthier, fewer cardiovascular risk factors, better baseline cognition
2. ARIC cohort participants (recruited from a longstanding cardiovascular study) — older, more cardiovascular risk, worse baseline cognition — i.e., the people at higher risk of dementia

In the high-risk ARIC subgroup, hearing aids produced a 48% relative reduction in 3-year cognitive decline (p=0.0006 for the interaction). In the healthy subgroup, there was no effect — probably because cognitive decline was too slow over 3 years to detect a benefit.

The interpretation is nuanced but important: in people already on a trajectory toward dementia, treating hearing loss cut the rate of decline nearly in half over 3 years. That is a larger effect size than any approved Alzheimer's drug. The effect may not be detectable in healthy 70-year-olds over 3 years, but the mechanism is real, and the at-risk population is exactly the one that matters for public health.

A complementary analysis of UK Biobank data (Jiang et al. 2023, Lancet Public Health, PMID 37054721) — 437,704 participants — found that people with untreated hearing loss had 42% higher dementia risk, while hearing aid users had risk nearly identical to people with normal hearing. Observational, with the usual caveats, but the magnitude and direction match ACHIEVE.

Taken together: hearing aids work for cognition in the people most likely to benefit.

Why People Wait 10 Years

If hearing aids are the most evidence-backed midlife dementia intervention we have, why does the median person wait 7 to 10 years after first noticing hearing loss before getting fitted?

Three reasons, in order of size:

1. Stigma. Hearing aids are still associated with being old, frail, and declining. Glasses are not — they became culturally neutral decades ago. Hearing aids remain stigmatized even though modern models are nearly invisible, Bluetooth-enabled, and look like AirPods. The internal narrative "I don't need one yet" is almost always wrong by the time someone says it.

2. Cost and access. Traditional prescription hearing aids cost $4,000-$6,000 per pair and historically required multiple audiology visits. In October 2022, the FDA authorized over-the-counter hearing aids for adults with mild-to-moderate hearing loss, dropping the price floor to $200-$1,000 and removing the prescription requirement. This changed the calculus but is still underused.

3. Gradual onset. Age-related hearing loss — presbycusis (the progressive, symmetric high-frequency hearing loss that comes with aging) — develops over years. You lose consonants before vowels, which means you still hear people but can't always tell what they said. The brain compensates, you turn up the TV, you start reading lips, you blame other people for mumbling. By the time the problem is obvious, a decade has passed and brain volume loss has accumulated.

The Lancet data implies that every year of delay is a year of avoidable cognitive risk. The stigma is expensive in ways most people don't calculate.

When to Get Your Hearing Tested

There is no universal consensus on adult hearing screening — the US Preventive Services Task Force issued an "insufficient evidence" statement in 2021, before ACHIEVE was published. The American Academy of Otolaryngology and most audiologists recommend something more assertive:

• Baseline audiogram (pure-tone hearing test) at age 50, then every 3 years
• Earlier and more frequent if you have any of: occupational noise exposure, frequent concert/club attendance, regular firearm use, tinnitus (ringing in the ears), family history of early hearing loss, or any subjective concern
• Immediately if you notice trouble following conversations in restaurants, need to turn TV volume higher than others, or have ringing that won't go away

A full audiogram takes 30-60 minutes, is painless, and is typically covered by insurance with a physician referral. Many Costco warehouses and national hearing chains offer free screenings.

If you already have hearing aids and they're more than 5 years old — get a new audiogram and an updated fitting. Modern devices are dramatically better.

How to Protect Your Hearing Starting Today

Hearing loss is largely preventable if you manage three variables: decibels, distance, and duration. This is the NIOSH framework, and it is simple enough to memorize.

• 85 decibels is the threshold above which noise damages the cochlea with prolonged exposure. Eight hours at 85 dB is the legal occupational limit.
• Every 3 dB above 85 halves the safe duration. So 88 dB = 4 hours safe. 91 dB = 2 hours. 94 dB = 1 hour. 100 dB = 15 minutes. 110 dB = under 2 minutes.

For reference: a normal conversation is ~60 dB. A busy restaurant is ~80 dB. A subway platform is 90-115 dB. A gas-powered lawnmower is ~90 dB. A rock concert is 100-120 dB. A gunshot is 140-165 dB — enough to cause permanent damage from a single exposure without hearing protection.

Practical rules:

• Download a decibel meter app (NIOSH Sound Level Meter on iOS is free and validated). Measure your daily environments. Most people are shocked.
• Wear earplugs at concerts, clubs, and loud sporting events. Modern high-fidelity musician's earplugs (~$25) attenuate volume without muffling fidelity. You can still hear the music clearly — just 15-25 dB quieter.
• Use hearing protection for power tools, lawn equipment, motorcycling, and firearms, always. No exceptions.
• Lower earbud volume to 60% or less, limit to 60 minutes at a time. WHO's 60/60 rule. Modern devices can tell you your weekly exposure — check it.
• Treat ear infections and middle ear fluid promptly. Untreated chronic infection damages hearing.

One more independent risk factor worth naming: smoking. Multiple cohort studies link current smoking to faster progression of hearing loss and higher dementia risk independently. Quitting helps both.

Tinnitus and Ototoxic Medications

Two related ear issues deserve a mention.

Tinnitus — persistent ringing, buzzing, or hissing in the ears with no external source — affects roughly 15% of US adults. It is usually a symptom of underlying hearing damage, not an isolated condition. Chronic tinnitus has been associated with elevated dementia risk in some cohorts (a 2020 Taiwan population study, Chu et al., PMID 32284390, reported HR 1.68). If you have tinnitus, get a hearing test. Even if you don't perceive hearing loss, there likely is some.

Ototoxic medications are drugs that can damage the inner ear. The main ones:

• Aminoglycoside antibiotics (gentamicin, tobramycin, amikacin) — used for serious infections
• Cisplatin and related platinum chemotherapies
• Loop diuretics at high IV doses (furosemide, bumetanide)
• High-dose aspirin and NSAIDs (usually reversible)
• Quinine and some antimalarials

If you have been or will be on any of these long-term, ask your physician or audiologist for baseline and monitoring audiograms. Dose reduction or alternative drugs can sometimes prevent permanent damage if caught early.

What You Can Do — The Evidence-Based Action List

Ranked by strength of evidence for protecting your brain through your ears:

1. Get a baseline audiogram at age 50 (sooner if you have any exposure history or symptoms). Repeat every 3 years. Every year if you already have measurable loss.
2. Treat any hearing loss aggressively. If you have measurable loss on an audiogram, get fitted for hearing aids — prescription or OTC — and wear them consistently. The evidence is strongest for people already at elevated cognitive risk. Do not wait 10 years.
3. Protect from loud sound using decibels-distance-duration. Earplugs at concerts. Over-ear protection for power tools. 60/60 rule for earbuds. The damage is cumulative and permanent.
4. Quit smoking. Independent risk factor for both hearing loss progression and dementia.
5. Maintain cardiovascular health. Hypertension and high LDL cholesterol are both on the Lancet list, and both are linked to small-vessel disease in the cochlea as well as the brain. Treating blood pressure protects your ears as well as your neurons.
6. Stay socially engaged. If hearing aids fix the input side, your job is to keep using the output. Conversations, groups, classes, community. Don't let hearing loss — or vanity about treating it — shrink your social world.
7. Ask about ototoxic medications. If you're prescribed any of the drug classes listed above, ask whether baseline or monitoring audiograms are warranted.

FAQ

Do hearing aids really work for cognition, or is the evidence weaker than people claim? The honest answer is: yes, but with important nuance. The ACHIEVE trial (PMID 37478886) — the only large RCT to date — was null in the overall population of 977 older adults over 3 years. The 48% reduction in cognitive decline was found only in a pre-specified high-risk subgroup (older adults with cardiovascular risk and worse baseline cognition). That finding is biologically plausible, statistically robust, and consistent with large observational data (UK Biobank, PMID 37054721), but you should not claim that "hearing aids prevent dementia in everyone." You should claim: in people already on a dementia trajectory, hearing aids can meaningfully slow decline — a larger effect than any currently approved Alzheimer's drug.

How loud is too loud in daily life? Above 85 dB with prolonged exposure. A rough rule: if you have to raise your voice to be heard by someone an arm's length away, the ambient noise is ~85 dB or louder. Download a decibel meter app and measure. Most people underestimate their environment.

Does mild hearing loss actually matter, or should I wait until it's severe? It matters. The dose-response relationship in Lin et al. 2011 (PMID 21320988) showed mild hearing loss already conferred roughly a 2-fold increased dementia risk, moderate HL a 3-fold, severe a 5-fold. The mechanistic damage — cognitive load, atrophy, social withdrawal — starts early. Waiting for "severe" loss is how the 7-10 year treatment delay happens.

Are over-the-counter hearing aids as good as prescription? For mild-to-moderate hearing loss in adults, modern OTC hearing aids (authorized by FDA in October 2022) perform well for many users and cost 80-90% less than traditional prescription devices. For moderate-to-severe loss, more complex audiograms, or asymmetric loss, you still want a professional audiologist. An audiogram first will tell you which category you're in.

What about tinnitus — can it be cured? Most chronic tinnitus cannot be fully cured, but many cases can be significantly managed with hearing aids (which often reduce tinnitus by amplifying ambient sound), sound therapy, cognitive behavioral therapy, and treatment of any underlying hearing loss. If tinnitus is new, sudden, one-sided, or accompanied by vertigo, see an ENT promptly — those presentations can indicate treatable causes.

Does listening to music at safe volumes protect the brain or damage it? Music at safe volumes (under 85 dB, or 60% earbud volume for under 60 minutes) is protective. It engages auditory networks, motor networks, and emotional circuits, and observational data associate musical engagement with better cognitive aging. The danger is volume and duration, not music itself.

The Bottom Line

For 20 years, dementia prevention advice has centered on the usual suspects: exercise, diet, don't smoke, manage blood pressure, stay social. All still true. All still matter.

But the single largest modifiable risk factor in midlife — the one intervention with the biggest potential public-health impact on brain aging — is the one almost nobody talks about at dinner parties. Treat your hearing. Get tested at 50. Wear hearing aids if you need them. Protect your ears from loud sound starting now. Ask whether any of your medications are ototoxic.

The Lancet Commission has said this, with precise numbers, three times in seven years. The ACHIEVE trial has shown that the intervention works in the people who need it most. The stigma is a cultural artifact — not a medical reality.

Your ears are part of your brain. Treat them that way.

References (selected)

1. Livingston G, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 2024 Aug 10. PMID 39096926.
2. Livingston G, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020 Aug 8;396(10248):413-446. PMID 32738937.
3. Lin FR, Pike JR, Albert MS, et al. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. The Lancet. 2023 Sep 2;402(10404):786-797. PMID 37478886.
4. Jiang F, Mishra SR, Shrestha N, et al. Association between hearing aid use and all-cause and cause-specific dementia: an analysis of the UK Biobank cohort. Lancet Public Health. 2023 May;8(5):e329-e338. PMID 37054721.
5. Lin FR, Metter EJ, O'Brien RJ, et al. Hearing loss and incident dementia. Arch Neurol. 2011 Feb;68(2):214-20. PMID 21320988.
6. Lin FR, Yaffe K, Xia J, et al. Hearing loss and cognitive decline in older adults. JAMA Intern Med. 2013 Feb 25;173(4):293-9. PMID 23337978.
7. Lin FR, Ferrucci L, An Y, et al. Association of hearing impairment with brain volume changes in older adults. Neuroimage. 2014 Apr 15;90:84-92. PMID 24412398.
8. Deal JA, Betz J, Yaffe K, et al. Hearing Impairment and Incident Dementia and Cognitive Decline in Older Adults: The Health ABC Study. J Gerontol A Biol Sci Med Sci. 2017 May 1;72(5):703-709. PMID 27071780.
9. Livingston G, et al. Dementia prevention, intervention, and care. The Lancet. 2017 Dec 16;390(10113):2673-2734. PMID 28735855.
10. Chu HT, Liang CS, Yeh TC, et al. Tinnitus and risk of Alzheimer's and Parkinson's disease: a retrospective nationwide population-based cohort study. Sci Rep. 2020 Jul 14;10(1):12134. PMID 32284390.

This article is educational and does not constitute medical advice. If you suspect hearing loss or are concerned about cognitive symptoms, consult a licensed audiologist and physician.